About Mert Aktar
Mert Aktar is a director at Kyverna Therapeutics.
Form D filings name Mert Aktar as a director at ReAlta Life Sciences.
Mert Aktar reports to the SEC as a director of 1 public company.
Mert Aktar first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mert Aktar in the role, so the role may have started earlier or lasted longer.
KI
Key Colleagues at Startups
The people Mert Aktar works with at each company, as listed on that company's latest Form D.
ReAlta Life Sciences, Inc. · Form D, May 21, 2025
AM
Andrew Miller
Director
PM
Paolo Martini
Executive officer
FG
Frank Gadams
Director
LG
Laurie Glimcher
Director
JR
John Rickman
Chief Financial Officer
DM
David Marek
Executive officer and director
NK
Neel Krishna
Executive officer
LW
Lewis Williams
Director
KC
Kenji Cunnion
Executive officer
CS
Christi Shaw
Director
ER
Emma Reeve
Director
EJ
Edward Heidt, Jr.
Director